Distribution of human papillomavirus prevalence, genotype, and PAP test results in women in the southeast of Turkey

被引:0
作者
Aydogdu, Gulay [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Pathol, Div Cytopatol, Diyarbakir, Turkiye
来源
CIRUGIA Y CIRUJANOS | 2023年 / 91卷 / 03期
关键词
Human Papillomavirus; DNA tests; Prevalence; Genotype; CERVICAL-CANCER; PREVENTION; CYTOLOGY; IMPACT; RISK;
D O I
10.24875/CIRU.22000400
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The aim of this study was to investigate the prevalence, genotype, and distribution of cervical human papillomavirus (HPV) in women living in southeast Turkey. Materials and methods. A total of 13,300 cervical smear materials were scanned and 899 cases found to be HPV-positive were included in the study. Cases were divided into seven groups according to age (under 19 years of age, 20-24, 25-29, 30-39, 40-49, 50-59, and over 60 years old) and six groups according to HPV types (HPV type 16, HPV type 18, HPV type 16-18 association, HPV type 16-high risk (HR) association, HPV Type 18-HR association, and HPV HR [31,33,35,39,45, 51,52,56,58,59,66, and 681). SurePath liquid-based cytology preparations were evaluated, and HPV tests were performed using real-time-polymerase chain reaction. Results. A total of 6.7% of cervical smear samples were positive for HPV DNA. The mean age of these cases was 41 years (range 15-78 years). All HPV types showed the highest rate of positivity in the 30-39 age groups. Regarding the distribution of HPV types, most of the cases were in the HPV HR group (66%). The most common atypia category detected in cytological examination was "Atypical squamous cells of undetermined significance" (ASC-US) (27%). Conclusions. It was determined that the prevalence of HPV in the southeast of Turkey is lower than the world average, the most common HPV type in our region is HPV-HR, and HPV peaks at older ages compared to what has been reported for other regions of the world.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 30 条
  • [1] Akay E, 2019, ANN MED RES, V1, P1
  • [2] Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
    Arbyn, Marc
    Ronco, Guglielmo
    Anttila, Ahti
    Meijer, Chris J. L. M.
    Poljak, Mario
    Ogilvie, Gina
    Koliopoulos, George
    Naucler, Pontus
    Sankaranarayanan, Rengaswamy
    Peto, Julian
    [J]. VACCINE, 2012, 30 : F88 - F99
  • [3] Prevalence and age-wise distribution of Human Papillomavirus type 16/18 infections among hospital screened women of a peri-urban area in West Bengal: Impact of socio-demographic factors
    Bhattacharya, Amrapali
    Sen, Shrinka
    Mandal, Paramita
    Saha, Sweta Sharma
    Sarkara, Somosree
    Pathak, Om Prakash
    Biswas, Lena
    Roy, Jayeeta
    Banerjee, Rimpa
    Chowdhury, Ranita Roy
    Pal, Manidip
    Mukherjee, Ankur
    Sengupta, Sharmila
    [J]. CANCER EPIDEMIOLOGY, 2018, 54 : 31 - 37
  • [4] The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium
    Bonde, Jesper
    Ejegod, Ditte Moller
    Cuschieri, Kate
    Dillner, Joakim
    Heideman, Danielle A. M.
    Quint, Wim
    Pavon Ribas, Miguel Angel
    Padalko, Elizaveta
    Christiansen, Irene Kraus
    Xu, Lan
    Arbyn, Marc
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2018, 108 : 64 - 71
  • [5] Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
    Brisson, Marc
    Kim, Jane J.
    Canfell, Karen
    Drolet, Melanie
    Gingras, Guillaume
    Burger, Emily A.
    Martin, Dave
    Simms, Kate T.
    Benard, Elodie
    Boily, Marie-Claude
    Sy, Stephen
    Regan, Catherine
    Keane, Adam
    Caruana, Michael
    Nguyen, Diep T. N.
    Smith, Megan A.
    Laprise, Jean-Francois
    Jit, Mark
    Alary, Michel
    Bray, Freddie
    Fidarova, Elena
    Elsheikh, Fayad
    Bloem, Paul J. N.
    Broutet, Nathalie
    Hutubessy, Raymond
    [J]. LANCET, 2020, 395 (10224) : 575 - 590
  • [6] Cibas ES, 2021, CERVICAL VAGINAL CYT, V5th, P1
  • [7] Human papillomavirus and cervical cancer
    Crosbie, Emma J.
    Einstein, Mark H.
    Franceschi, Silvia
    Kitchener, Henry C.
    [J]. LANCET, 2013, 382 (9895) : 889 - 899
  • [8] Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology:: a meta-analysis
    de Sanjose, Silvia
    Diaz, Mireia
    Castellsague, Xavier
    Clifford, Gary
    Bruni, Laia
    Munoz, Nubia
    Bosch, F. Xavier
    [J]. LANCET INFECTIOUS DISEASES, 2007, 7 (07) : 453 - 459
  • [9] HPV infection in Europe
    De Vuyst, Hugo
    Clifford, Gary
    Li, Ni
    Franceschi, Silvia
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (15) : 2632 - 2639
  • [10] HPV Types in Turkey: Multicenter Hospital Based Evaluation of 6388 Patients in Turkish Gynecologic Oncology Group Centers
    Dursun, Polat
    Ayhan, Ali
    Mutlu, Levent
    Caglar, Mete
    Haberal, Ali
    Gungor, Taygun
    Ozat, Mustafa
    Ozgu, Emre
    Onan, Anil
    Taskiran, Cagatay
    Guner, Haldun
    Yetimalar, Hakan
    Kasap, Burcu
    Yuce, Kunter
    Salman, M. Coskun
    Sayal, Berkan
    Dogan, Selen
    Harma, Muge
    Harma, Mehmet
    Basaran, Mustafa
    Aydogmus, Huseyin
    Ergun, Yusuf
    Sehirali, Salim
    Gultekin, Emre
    Kose, Sukran
    Yildirim, Yusuf
    Yenen, Mufit
    Dede, Murat
    Alanbay, Ibrahim
    Karaca, Riza
    Metindir, Jale
    Keskin, Levent
    Ustuner, Isik
    Avsar, Filiz
    Yuksel, Hasan
    Kirdar, Selim
    [J]. TURKISH JOURNAL OF PATHOLOGY, 2013, 29 (03) : 210 - 216